@article{MTMT:34103124, title = {Adherence to inhaled corticosteroids and long-acting β2-agonists in asthma: A MASK-air study}, url = {https://m2.mtmt.hu/api/publication/34103124}, author = {Sousa-Pinto, B. and Louis, R. and Anto, J.M. and Amaral, R. and Sá-Sousa, A. and Czarlewski, W. and Brussino, L. and Canonica, G.W. and Chaves, Loureiro C. and Cruz, A.A. and Gemicioglu, B. and Haahtela, T. and Kupczyk, M. and Kvedariene, V. and Larenas-Linnemann, D.E. and Okamoto, Y. and Ollert, M. and Pfaar, O. and Pham-Thi, N. and Puggioni, F. and Regateiro, F.S. and Romantowski, J. and Sastre, J. and Scichilone, N. and Taborda-Barata, L. and Ventura, M.T. and Agache, I. and Bedbrook, A. and Becker, S. and Bergmann, K.C. and Bosnic-Anticevich, S. and Bonini, M. and Boulet, L.-P. and Brusselle, G. and Buhl, R. and Cecchi, L. and Charpin, D. and de, Blay F. and Del, Giacco S. and Ivancevich, J.C. and Jutel, M. and Klimek, L. and Kraxner, Helga and Kuna, P. and Laune, D. and Makela, M. and Morais-Almeida, M. and Nadif, R. and Niedoszytko, M. and Papadopoulos, N.G. and Papi, A. and Patella, V. and Pétré, B. and Rivero, Yeverino D. and Robalo, Cordeiro C. and Roche, N. and Rouadi, P.W. and Samolinski, B. and Savouré, M. and Shamji, M.H. and Sheikh, A. and Suppli, Ulrik C. and Usmani, O.S. and Valiulis, A. and Yorgancioglu, A. and Zuberbier, T. and Fonseca, J.A. and Costa, E.M. and Bousquet, J.}, doi = {10.1016/j.pulmoe.2023.07.004}, journal-iso = {PULMONOLOGY}, journal = {PULMONOLOGY}, volume = {31}, unique-id = {34103124}, issn = {2531-0429}, abstract = {Introduction: Adherence to controller medication is a major problem in asthma management, being difficult to assess and tackle. mHealth apps can be used to assess adherence. We aimed to assess the adherence to inhaled corticosteroids+long-acting β2-agonists (ICS+LABA) in users of the MASK-air® app, comparing the adherence to ICS+formoterol (ICS+F) with that to ICS+other LABA. Materials and methods: We analysed complete weeks of MASK-air® data (2015-2022; 27 countries) from patients with self-reported asthma and ICS+LABA use. We compared patients reporting ICS+F versus ICS+other LABA on adherence levels, symptoms and symptom-medication scores. We built regression models to assess whether adherence to ICS+LABA was associated with asthma control or short-acting beta-agonist (SABA) use. Sensitivity analyses were performed considering the weeks with no more than one missing day. Results: In 2598 ICS+LABA users, 621 (23.9%) reported 4824 complete weeks and 866 (33.3%) reported weeks with at most one missing day. Higher adherence (use of medication ≥80% of weekly days) was observed for ICS+other LABA (75.1%) when compared to ICS+F (59.3%), despite both groups displaying similar asthma control and work productivity. The ICS+other LABA group was associated with more days of SABA use than the ICS+F group (median=71.4% versus 57.1% days). Each additional weekly day of ICS+F use was associated with a 4.1% less risk in weekly SABA use (95%CI=-6.5;-1.6%;p=0.001). For ICS+other LABA, the percentage was 8.2 (95%CI=-11.6;-5.0%;p<0.001). Conclusions: In asthma patients adherent to the MASK-air app, adherence to ICS+LABA was high. ICS+F users reported lower adherence but also a lower SABA use and a similar level of control. © 2023 Sociedade Portuguesa de Pneumologia}, keywords = {Inhaled corticosteroids; Asthma; Adherence; Formoterol; Long-acting-β2 agonist}, year = {2025}, eissn = {2531-0437}, orcid-numbers = {Kraxner, Helga/0000-0002-0331-5345} } @article{MTMT:36012692, title = {Adherence to Treatment in Allergic Rhinitis During the Pollen Season in Europe: A MASK-air Study}, url = {https://m2.mtmt.hu/api/publication/36012692}, author = {Sousa-Pinto, B. and Costa, E.M. and Vieira, R.J. and Klimek, L. and Czarlewski, W. and Pfaar, O. and Bedbrook, A. and Amaral, R. and Brussino, L. and Kvedariene, V. and Larenas-Linnemann, D.E. and Iinuma, T. and Pham-Thi, N. and Regateiro, F.S. and Taborda-Barata, L. and Ventura, M.T. and Ansotegui, I.J. and Bergmann, K.C. and Canonica, G.W. and Cardona, V. and Cecchi, L. and Cherrez-Ojeda, I. and Cingi, C. and Cruz, A.A. and Del, Giacco S. and Devillier, P. and Fokkens, W.J. and Gemicioglu, B. and Haahtela, T. and Ivancevich, J.C. and Kuna, P. and Kraxner, Helga and Laune, D. and Louis, R. and Makris, M. and Morais-Almeida, M. and Mösges, R. and Niedoszytko, M. and Papadopoulos, N.G. and Patella, V. and Pereira, A.M. and Reitsma, S. and Robles-Velasco, K. and Rouadi, P.W. and Samolinski, B. and Sova, M. and Toppila-Salmi, S.K. and Sastre, J. and Valiulis, A. and Yorgancioglu, A. and Zidarn, M. and Zuberbier, T. and Fonseca, J.A. and Bousquet, J.}, doi = {10.1111/cea.70004}, journal-iso = {CLIN EXP ALLERGY}, journal = {CLINICAL AND EXPERIMENTAL ALLERGY}, volume = {55}, unique-id = {36012692}, issn = {0954-7894}, year = {2025}, eissn = {1365-2222}, pages = {226-238}, orcid-numbers = {Kraxner, Helga/0000-0002-0331-5345} } @{MTMT:36052072, title = {Fül-orr-gégészeti allergiák}, url = {https://m2.mtmt.hu/api/publication/36052072}, author = {Hirschberg, Andor and Kraxner, Helga}, booktitle = {Klinikai immunológia}, unique-id = {36052072}, year = {2025}, pages = {864-872}, orcid-numbers = {Hirschberg, Andor/0000-0001-9929-3875; Kraxner, Helga/0000-0002-0331-5345} } @article{MTMT:36391236, title = {Allergic Rhinitis and its Impact on Asthma (ARIA) Classes in MASK-air Users}, url = {https://m2.mtmt.hu/api/publication/36391236}, author = {Sousa-Pinto, B. and Savoure, M. and Vieira, R.J. and Amaral, R. and Czarlewski, W. and Bedbrook, A. and Valiulis, A. and Kvedariene, V. and Brussino, L. and Gemicioǧlu, B. and Haahtela, T. and Klimek, L. and Kraxner, Helga and Larenas-Linnemann, D.E. and Pfaar, O. and Regateiro, F.S. and Samoliński, B. and Taborda-Barata, L. and Toppila-Salmi, S. and Ventura, M.T. and Ansótegui, I.J. and Braido, F. and Canonica, G.W. and Cecchi, L. and Cruz, A.A. and Devillier, P. and Fokkens, W.J. and Gil-Mata, S. and Ivancevich, J.C. and Kuna, P. and Kupczyk, M. and Louis, G. and Louis, R. and Makris, M. and Monti, M. and Mullol, J. and Nadif, R. and Niedoszytko, M. and Okamoto, Y. and Ollert, M. and Papadopoulos, N.G. and Patella, V. and Pawankar, R. and Pereira, A.M. and Pétré, B. and Pham-Thi, N. and Roche, N. and Rouadi, P.W. and Sastre, J. and Scichilone, N. and Sheikh, A. and Sova, M. and Todo‑Bom, A. and Yorgancioǧlu, A. and Zidarn, M. and Antò, J.M. and Zuberbier, T. and Fonseca, J.A. and Bousquet, J.}, doi = {10.18176/jiaci.1047}, journal-iso = {J INVEST ALLERG CLIN IMMUNOL}, journal = {JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY}, volume = {35}, unique-id = {36391236}, issn = {1018-9068}, year = {2025}, eissn = {1698-0808}, pages = {373-383}, orcid-numbers = {Kraxner, Helga/0000-0002-0331-5345} } @article{MTMT:36847011, title = {Real-World Outcomes of 3-Month Olfactory Training on Post-COVID-19 Parosmia}, url = {https://m2.mtmt.hu/api/publication/36847011}, author = {Xu, Xinni and Ludanyi, Kristof Peter and Juratli, Jerry Hadi and Nemeth, Fruzsina and Nagy, Dávid and Kraxner, Helga and Hummel, Thomas}, doi = {10.1159/000549019}, journal-iso = {ORL J OTO-RHINO-LARY}, journal = {ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES}, volume = {87}, unique-id = {36847011}, issn = {0301-1569}, abstract = {Introduction: Post-COVID-19 parosmia can be protracted and psychologically distressing. The effect of olfactory training (OT) on parosmia is still unclear. The primary objective was to investigate the effect of 3 months of OT on COVID-19-related parosmia. The secondary objectives were to study whether improvement in olfactory quantitative function and compliance to OT influenced improvement in parosmia. Methods: This prospective cohort study was conducted from October 5, 2022, to February 7, 2023, at a tertiary smell and taste clinic. Patients with persistent post-COVID-19 parosmia were instructed to perform OT twice daily for 3 months. Improvement in parosmia was measured using self-rated intensity and pleasantness scales, a structured parosmia questionnaire, and the Sniffin' Sticks Parosmia Test (which measures hedonic direction and range). Quantitative olfactory function was measured with Sniffin' Sticks to determine the threshold, discrimination, and identification (TDI) score. Pre- and post-OT assessment of parosmia and quantitative olfactory function was performed. Compliance to OT was calculated as a percentage of the number of OT sessions performed over the expected number of training sessions over 3 months. Results: Thirty-eight patients (mean age 41.8 [+/- 13.3] years, 12 [31.6%] males) were recruited. After 3 months, 52.6% (n = 20) reported perceived improvement in parosmia. There was improvement in perceived pleasantness (-2.0 [-3.0 to -1.0] vs. -3.0 [-4.0 to -2.0], p = 0.027), hedonic range (2.4 [+/- 1.3] vs. 1.9 [+/- 1.6], p = 0.023), and TDI (27.9 [+/- 7.4] vs. 25.2 [+/- 7.2], p = 0.001) from baseline. All measures of parosmia did not differ significantly between patients who achieved the minimum clinically important difference of >= 5.5 in TDI scores versus those who did not. Patients who had >70% compliance to OT displayed more significant improvements in hedonic range (1.1 [+/- 1.1] vs. 0.2 [+/- 1.3] p = 0.04) compared to those who were less compliant. Conclusion: COVID-19-related parosmia and olfactory dysfunction improved with OT over 3 months. Improvement in olfactory function does not necessarily improve parosmia perception. However, compliance with OT appears to have an effect on improvement in parosmia.}, keywords = {olfactory dysfunction; olfactory training; parosmia}, year = {2025}, eissn = {1423-0275}, pages = {153-161}, orcid-numbers = {Kraxner, Helga/0000-0002-0331-5345} } @article{MTMT:34915949, title = {Real-life effectiveness of dupilumab in chronic rhinosinusitis with nasal polyps: results from eight Hungarian centres with 12-month follow-up}, url = {https://m2.mtmt.hu/api/publication/34915949}, author = {Kiricsi, Ágnes and Bella, Zsolt and Kraxner, Helga and Szalóki, Tibor and Fent, Zoltán and Liktor, Balázs and Huszka, J and Laszlo, P and Gobol, D and Helfferich, F and Vaska, Z and Piski, Zalán and Juhasz-Loisch, L and Horváth, Barnabás and Galantai, D and Krisztin, N and Tóth, László and Bodi, A and Matuz, Mária and Lujber, László and Hirschberg, Andor}, doi = {10.4193/Rhin23.278}, journal-iso = {RHINOLOGY}, journal = {RHINOLOGY}, volume = {62}, unique-id = {34915949}, issn = {0300-0729}, abstract = {Background: Research on the immune mechanism behind chronic rhinosinusitis (CRS) has revealed various new endotypes, leading to targeted therapies, especially for severe uncontrolled CRS. Biologics are novel therapeutic strategies providing targeted treatment for the difficult-to-treat recalcitrant CRSwNP patients. Dupilumab is a fully human-derived monoclonal antibody that binds to IL4Rα, inhibiting the signalling of both IL-4 and IL-13. In Hungary, it is approved for the treatment of uncontrolled CRSwNP according to criteria based on the EPOS2020 and the Hungarian guidelines. Methodology: This study aimed to collect and evaluate real-world therapeutic data of CRSwNP patients treated with dupilumab. One hundred thirty-five patients from eight different referral centres have been enrolled in this study, who received dupilumab since 2020. All subjects were adult patients (>18 years) with uncontrolled CRSwNP. Baseline data collection included demographics, medical history, previous surgeries, related comorbidities, total endoscopic nasal polyp score (NPS), SNOT22, nasal congestion parameters measured with visual analogue scale (VAS) and nasal obstruction evaluation scale (NOSE), loss of smell score (LSS) and eosinophil count. 300 mg dupilumab was administered subcutaneously every second week. Follow up visits were performed after 6 and 12 months. Results: After 6 and 12 months of treatment significant improvement was detected in all clinical parameters. Safety was proved, no severe side effects occurred, and no rescue treatment was necessary. Conclusions: Our real-life findings show that continuous dupilumab treatment is effective and safe in daily clinical practice in CRSwNP and other type 2 comorbidities such as bronchial asthma and NERD.}, year = {2024}, eissn = {0300-0729}, pages = {410-420}, orcid-numbers = {Kraxner, Helga/0000-0002-0331-5345; Szalóki, Tibor/0000-0001-8759-9164; Fent, Zoltán/0000-0002-3559-0886; Piski, Zalán/0000-0003-2592-9652; Matuz, Mária/0000-0002-7877-2399; Hirschberg, Andor/0000-0001-9929-3875} } @article{MTMT:35420761, title = {Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)}, url = {https://m2.mtmt.hu/api/publication/35420761}, author = {Bousquet, J. and Schünemann, H.J. and Sousa-Pinto, B. and Zuberbier, T. and Togias, A. and Samolinski, B. and Bedbrook, A. and Czarlewski, W. and Hofmann-Apitius, M. and Litynska, J. and Vieira, R.J. and Anto, J.M. and Fonseca, J.A. and Brozek, J. and Bognanni, A. and Brussino, L. and Canonica, G.W. and Cherrez-Ojeda, I. and Cruz, A.A. and Vecillas, L.D.L. and Dykewicz, M. and Gemicioglu, B. and Giovannini, M. and Haahtela, T. and Jacobs, M. and Jacomelli, C. and Klimek, L. and Kvedariene, V. and Larenas-Linnemann, D.E. and Louis, G. and Lourenço, O. and Leemann, L. and Morais-Almeida, M. and Neves, A.L. and Nadeau, K.C. and Nowak, A. and Palamarchuk, Y. and Palkonen, S. and Papadopoulos, N.G. and Parmelli, E. and Pereira, A.M. and Pfaar, O. and Regateiro, F.S. and Savouré, M. and Taborda-Barata, L. and Toppila-Salmi, S.K. and Torres, M.J. and Valiulis, A. and Ventura, M.T. and Williams, S. and Yepes-Nuñez, J.J. and Yorgancioglu, A. and Zhang, L. and Zuberbier, J. and Abdul, Latiff A.H. and Abdullah, B. and Agache, I. and Al-Ahmad, M. and Al-Nesf, M.A. and Al, Shaikh N.A. and Amaral, R. and Ansotegui, I.J. and Asllani, J. and Balotro-Torres, M.C. and Bergmann, K.-C. and Bernstein, J.A. and Bindslev-Jensen, C. and Blaiss, M.S. and Bonaglia, C. and Bonini, M. and Bossé, I. and Braido, F. and Caballero-Fonseca, F. and Camargos, P. and Carreiro-Martins, P. and Casale, T. and Castillo-Vizuete, J.-A. and Cecchi, L. and Teixeira, M.D.C. and Chang, Y.-S. and Loureiro, C.C. and Christoff, G. and Ciprandi, G. and Cirule, I. and Correia-de-Sousa, J. and Costa, E.M. and Cvetkovski, B. and de, Vries G. and Del, Giacco S. and Devillier, P. and Dokic, D. and Douagui, H. and Durham, S.R. and Enecilla, M.L. and Fiocchi, A. and Fokkens, W.J. and Fontaine, J.-F. and Gawlik, R. and Gereda, J.E. and Gil-Mata, S. and Giuliano, A.F.M. and Gotua, M. and Gradauskiene, B. and Guzman, M.A. and Hossny, E. and Hrubiško, M. and Iinuma, T. and Irani, C. and Ispayeva, Z. and Ivancevich, J.C. and Jartti, T. and Jeseňák, M. and Julge, K. and Jutel, M. and Kaidashev, I. and Bennoor, K.S. and Khaltaev, N. and Kirenga, B. and Kraxner, Helga and Kull, I. and Kulus, M. and Kuna, P. and Kupczyk, M. and Kurchenko, A. and La, Grutta S. and Lane, S. and Miculinic, N. and Lee, S.M. and Le, Thi Tuyet L. and Lkhagvaa, B. and Louis, R. and Mahboub, B. and Makela, M. and Makris, M. and Maurer, M. and Melén, E. and Milenkovic, B. and Mohammad, Y. and Moniuszko, M. and Montefort, S. and Moreira, A. and Moreno, P. and Mullol, J. and Nadif, R. and Nakonechna, A. and Navarro-Locsin, C.G. and Neffen, H.E. and Nekam, K. and Niedoszytko, M. and Nunes, E. and Nyembue, D. and O'Hehir, R. and Ollert, M. and Ohta, K. and Okamoto, Y. and Okubo, K. and Olze, H. and Padukudru, M.A. and Palomares, O. and Pali-Schöll, I. and Panzner, P. and Palosuo, K. and Park, H.S. and Passalacqua, G. and Patella, V. and Pawankar, R. and Pétré, B. and Pitsios, C. and Plavec, D. and Popov, T.A. and Puggioni, F. and Quirce, S. and Raciborski, F. and Ramonaité, A. and Recto, M. and Repka-Ramirez, S. and Roberts, G. and Robles-Velasco, K. and Roche, N. and Rodriguez-Gonzalez, M. and Romualdez, J.A. and Rottem, M. and Rouadi, P.W. and Salapatas, M. and Sastre, J. and Serpa, F.S. and Sayah, Z. and Scichilone, N. and Senna, G. and Sisul, J.C. and Solé, D. and Soto-Martinez, M.E. and Sova, M. and Sozinova, O. and Stevanovic, K. and Ulrik, C.S. and Szylling, A. and Tan, F.M. and Tantilipikorn, P. and Todo-Bom, A. and Tomic-Spiric, V. and Tsaryk, V. and Tsiligianni, I. and Urrutia-Pereira, M. and Rostan, M.V. and Sofiev, M. and Valovirta, E. and Van, Eerd M. and Van, Ganse E. and Vasankari, T. and Vichyanond, P. and Viegi, G. and Wallace, D. and Wang, D.Y. and Waserman, S. and Wong, G. and Worm, M. and Yusuf, O.M. and Zaitoun, F. and Zidarn, M.}, doi = {10.1016/j.jaip.2024.06.040}, journal-iso = {J ALLERGY CLIN IMMUNOL PRACT}, journal = {JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY: IN PRACTICE}, volume = {12}, unique-id = {35420761}, issn = {2213-2198}, year = {2024}, eissn = {2213-2201}, pages = {2648-2668.e2}, orcid-numbers = {Kraxner, Helga/0000-0002-0331-5345} } @article{MTMT:33424326, title = {Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK-air® longitudinal study}, url = {https://m2.mtmt.hu/api/publication/33424326}, author = {Sousa-Pinto, B. and Schünemann, H.J. and Sá-Sousa, A. and Vieira, R.J. and Amaral, R. and Anto, J.M. and Klimek, L. and Czarlewski, W. and Mullol, J. and Pfaar, O. and Bedbrook, A. and Brussino, L. and Kvedariene, V. and Larenas-Linnemann, D.E. and Okamoto, Y. and Ventura, M.T. and Agache, I. and Ansotegui, I.J. and Bergmann, K.C. and Bosnic-Anticevich, S. and Canonica, G.W. and Cardona, V. and Carreiro-Martins, P. and Casale, T. and Cecchi, L. and Chivato, T. and Chu, D.K. and Cingi, C. and Costa, E.M. and Cruz, A.A. and Del, Giacco S. and Devillier, P. and Eklund, P. and Fokkens, W.J. and Gemicioglu, B. and Haahtela, T. and Ivancevich, J.C. and Ispayeva, Z. and Jutel, M. and Kuna, P. and Kaidashev, I. and Khaitov, M. and Kraxner, Helga and Laune, D. and Lipworth, B. and Louis, R. and Makris, M. and Monti, R. and Morais-Almeida, M. and Mösges, R. and Niedoszytko, M. and Papadopoulos, N.G. and Patella, V. and Pham-Thi, N. and Regateiro, F.S. and Reitsma, S. and Rouadi, P.W. and Samolinski, B. and Sheikh, A. and Sova, M. and Todo-Bom, A. and Taborda-Barata, L. and Toppila-Salmi, S. and Sastre, J. and Tsiligianni, I. and Valiulis, A. and Vandenplas, O. and Wallace, D. and Waserman, S. and Yorgancioglu, A. and Zidarn, M. and Zuberbier, T. and Fonseca, J.A. and Bousquet, J.}, doi = {10.1111/all.15574}, journal-iso = {ALLERGY}, journal = {ALLERGY: EUROPEAN JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY}, volume = {78}, unique-id = {33424326}, issn = {0105-4538}, year = {2023}, eissn = {1398-9995}, pages = {968-983}, orcid-numbers = {Kraxner, Helga/0000-0002-0331-5345} } @article{MTMT:33605666, title = {The Correlation between the Results of the Sniffin’ Sticks Test, Demographic Data, and Questionnaire of Olfactory Disorders in a Hungarian Population after a SARS-CoV-2 Infection}, url = {https://m2.mtmt.hu/api/publication/33605666}, author = {Molnár, András and Maihoub, Stefani and Mavrogeni, Panayiota and Krasznai, Magdolna and Tamás, László and Kraxner, Helga}, doi = {10.3390/jcm12031041}, journal-iso = {J CLIN MED}, journal = {JOURNAL OF CLINICAL MEDICINE}, volume = {12}, unique-id = {33605666}, abstract = {Background: After a severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, smell disorders frequently occur, significantly affecting patients’ quality of life (QoL). Methods: 110 patients with persistent olfactory disorder after coronavirus infection were enrolled. These patients underwent chemosensory testing using the Sniffin’ Sticks test, and completed the Questionnaire of Olfactory Disorders (QOD). Results: 30% of the patients reported anosmia, and 70% reported hyposmia. Upon comparing subjective and chemosensory testing categories, good category matching was observed in 75.3% (i.e., anosmia based on both methods in 10 and hyposmia in 48 cases). Statistical analysis using the Chi-square test revealed a significant result (p = 0.001 *). Between the TDI (i.e., Threshold, Discrimination, Identification) results of the three subjective report groups (i.e., hyposmia, anosmia, and parosmia), no significant differences were observed. When the TDI and QOD results were compared, no consistent significant correlations were found in most TDI and QOD outcomes. Between the TDI and Scale 2 results, a significant, although slight correlation was observed by the Spearman’s (rho = 0.213, p = 0.027 *) and Pearson’s (rho = 0.201, p = 0.037 *) tests. Conclusions: The nonsignificant correlation between objective and subjective methods suggests that these results should be interpreted independently. Moreover, adequate management is essential even in mild cases.}, year = {2023}, eissn = {2077-0383}, orcid-numbers = {Molnár, András/0000-0002-4417-5166; Krasznai, Magdolna/0000-0002-7319-9300; Tamás, László/0000-0003-3723-9149; Kraxner, Helga/0000-0002-0331-5345} } @article{MTMT:33626642, title = {Digitally-enabled, patient-centred care in rhinitis and asthma multimorbidity: The ARIA-MASK-air® approach}, url = {https://m2.mtmt.hu/api/publication/33626642}, author = {Bousquet, J. and Anto, J.M. and Sousa-Pinto, B. and Czarlewski, W. and Bedbrook, A. and Haahtela, T. and Klimek, L. and Pfaar, O. and Kuna, P. and Kupczyk, M. and Regateiro, F.S. and Samolinski, B. and Valiulis, A. and Yorgancioglu, A. and Arnavielhe, S. and Basagaña, X. and Bergmann, K.C. and Bosnic-Anticevich, S. and Brussino, L. and Canonica, G.W. and Cardona, V. and Cecchi, L. and Chaves-Loureiro, C. and Costa, E. and Cruz, A.A. and Gemicioglu, B. and Fokkens, W.J. and Ivancevich, J.C. and Kraxner, Helga and Kvedariene, V. and Larenas-Linnemann, D.E. and Laune, D. and Louis, R. and Makris, M. and Maurer, M. and Melén, E. and Micheli, Y. and Morais-Almeida, M. and Mullol, J. and Niedoszytko, M. and Okamoto, Y. and Papadopoulos, N.G. and Patella, V. and Pham-Thi, N. and Rouadi, P.W. and Sastre, J. and Scichilone, N. and Sheikh, A. and Sofiev, M. and Taborda-Barata, L. and Toppila-Salmi, S. and Tsiligianni, I. and Valovirta, E. and Ventura, M.T. and Vieira, R.J. and Zidarn, M. and Amaral, R. and Ansotegui, I.J. and Bédard, A. and Benveniste, S. and Bewick, M. and Bindslev-Jensen, C. and Blain, H. and Bonini, M. and Bourret, R. and Braido, F. and Carreiro-Martins, P. and Charpin, D. and Cherrez-Ojeda, I. and Chivato, T. and Chu, D.K. and Cingi, C. and Del, Giacco S. and de, Blay F. and Devillier, P. and De, Vries G. and Doulaptsi, M. and Doyen, V. and Dray, G. and Fontaine, J.-F. and Gomez, R.M. and Hagemann, J. and Heffler, E. and Hofmann, M. and Jassem, E. and Jutel, M. and Keil, T. and Kritikos, V. and Kull, I. and Kulus, M. and Lourenço, O. and Mathieu-Dupas, E. and Menditto, E. and Mösges, R. and Murray, R. and Nadif, R. and Neffen, H. and Nicola, S. and O’Hehir, R. and Olze, H. and Palamarchuk, Y. and Pépin, J.-L. and Pétré, B. and Picard, R. and Pitsios, C. and Puggioni, F. and Quirce, S. and Raciborski, F. and Reitsma, S. and Roche, N. and Rodriguez-Gonzalez, M. and Romantowski, J. and Sá-Sousa, A. and Serpa, F.S. and Savouré, M. and Shamji, M.H. and Sova, M. and Sperl, A. and Stellato, C. and Todo-Bom, A. and Tomazic, P.V. and Vandenplas, O. and Van, Eerd M. and Vasankari, T. and Viart, F. and Waserman, S. and Fonseca, J.A. and Zuberbier, T.}, doi = {10.1002/clt2.12215}, journal-iso = {CLIN TRANSL ALLERGY}, journal = {CLINICAL AND TRANSLATIONAL ALLERGY}, volume = {13}, unique-id = {33626642}, issn = {2045-7022}, year = {2023}, eissn = {2045-7022}, orcid-numbers = {Kraxner, Helga/0000-0002-0331-5345} }